Veracyte
VCYT
$22.33
Share price
-2.53%
Change (1 day)
-10.86%
Change (1 year)
Market capitalization of Veracyte (VCYT)
Market cap: $1.62 Billion
As of October 2023 Veracyte has a market cap of $1.62 Billion. This makes Veracyte the world's 4218th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Veracyte from 2013 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $1.62 B | -4.59% |
| 2022 | $1.70 B | -41.83% |
| 2021 | $2.92 B | 3.3% |
| 2020 | $2.83 B | 104.5% |
| 2019 | $1.38 B | 169.53% |
| 2018 | $0.51 B | 131.27% |
| 2017 | $0.22 B | 2.75% |
| 2016 | $0.21 B | 8.53% |
| 2015 | $0.19 B | -8.38% |
| 2014 | $0.21 B | -29.03% |
| 2013 | $0.30 B |
End of Day market cap according to different sources
On Sep 30th, 2023 the market cap of Veracyte was reported to be:
$1.62 Billion
$1.62 Billion
$1.62 Billion
$1.62 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | $12.32 B | 658.68% | 🇺🇸 USA |
 Myriad Genetics MYGN | $1.31 B | -19.15% | 🇺🇸 USA |
 Biocept
BIOC | $3.28 M | -99.80% | 🇺🇸 USA |